10x Genomics (TXG) Free Cash Flow Growth (3y) (2021 - 2026)
10x Genomics (TXG) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.25 Bn | 24.94 Bn | 662.02 Mn | 30.79% |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 40.16% |
| 3 | Healthequity | 8.33 Bn | 8.07 Bn | 256.31 Mn | 37.45% |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | 70.93% |
| 6 | MiniMed | 4.49 Bn | 4.20 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.48 Bn | 4.41 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 38.38% |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | -55.52% |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | 69.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.93% |
| Dec 31, 2025 | 49.55% |
| Sep 30, 2025 | 43.26% |
| Jun 30, 2025 | 34.57% |
| Mar 31, 2025 | 38.61% |
| Dec 31, 2024 | 27.49% |
| Sep 30, 2024 | 29.91% |
| Jun 30, 2024 | -52.88% |
| Mar 31, 2024 | 25.69% |
| Dec 31, 2023 | 49.26% |
| Sep 30, 2023 | 34.55% |
| Jun 30, 2023 | 17.65% |
| Mar 31, 2023 | -17.25% |
| Dec 31, 2022 | -70.81% |
| Sep 30, 2022 | -52.00% |
| Jun 30, 2022 | -42.73% |
| Mar 31, 2022 | -115.72% |
| Dec 31, 2021 | 23.84% |